RCT | Rezafungin vs. caspofungin for treatment of candidaemia and invasive candidiasis.
29 Nov, 2022 | 13:54h | UTCRezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial – The Lancet (link to abstract – $ for full-text)